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Abstract The tz31]~4 subtype of neuronal nicotinic acetylcholine 
receptor (nAChR) was stably expressed in human embryonic 
kidney (HEK) 293 cells that co-expressed a voltage-gated Ca 2+ 
channel. ¢z3/134-nAChR-expressing clones were identified using 
the fura-2 Ca 2÷ imaging technique, and were further charac- 
terised by single-cell and whole-cell patch-clamp studies. 
Acetylcholine (ACh) induced fast activating currents which 
showed desensitisation and inward rectification. The conductance 
of the ACh-activated channel was 29 pS. The order of potency of 
the nicotinic agonists tested was cytisine -=- nicotine > acetylcho- 
line. The ECs0 value for ACh was 145 I~VI; the Hill coefficient 
was close to 2. The currents elicited by ACh were effectively 
blocked by nicotinic antagonists, but not by the muscarinic 
antagonist atropine. These properties are comparable to the 
pharmacological and physiological profile of ganglionic nicotinic 
receptors and type III currents of cultured Idppocampal neurons. 
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1. Introduction 
Neuronal nicotinic acetylcholine r ceptors (nAChR) exist in 
multiple subtypes and display functional diversity [1,2]. As has 
been concluded from subunit expression studies in Xenopus 
oocytes and mammalian cell lines, functional neuronal 
nAChRs are hetero-pentamers of a and 13 subunits, or homo- 
pentamers of ct subunits, [3-6]. To date, eight c~ subunits (a2- 
cOL which contain in their N-terminal extracellular domain 
vicinal cysteine residues characteristic of the ACh binding site, 
and three structural 13 subunits (132-134), which can modify the 
pharmacological nd functional properties of the nAChRs, 
have been identified. Because native neurons and neuronal 
cell lines usually express everal nAChR subtypes [7-10], the 
assignment of neuronal nicotinic responses to distinct nAChR 
subtypes is just at the beginning [10-14]. Ectopic expression 
systems for individual nAChR subtypes play an essential role 
in these studies. They are also important for drug screening 
and mechanistic studies, e.g. single-channel analysis. With a 
few notable exceptions [14,15], most ectopic expression sys- 
tems for neuronal nicotinic receptors o far are based on 
transient expression. It is not clear, at present, why stable 
ectopic expression of nAChRs is more difficult to achieve 
than for other ionotropic neuroreceptors [16-18]. 
Here we report on the stable expression of the ct3/134 sub- 
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type of nAChR in human embryonic kidney (HEK) 293 cells. 
a3 and 154 subunits are expressed, among others, in the chick- 
en superior cervical ganglion and the ciliary ganglion, and in 
PC12 cells [6,10,13,19,20], suggesting that the a3/134 subtype 
of nAChR is a major ganglionic nicotinic receptor. Transient 
expression of the ~3/134 nAChR subtype in HEK-293 cells has 
previously been achieved by others [21]. 
For the selection of cell clones stably expressing the ct3/134 
subtype of nAChR, we employed Ca 2+ imaging with the 
Ca2+-chelating a ent fura-2 [22]. By using as ectopic expres- 
sion system HEK-293 cells that stably express an L-type vol- 
tage-gated Ca 2+ channel (Loqc_ b [23]), we achieved high assay 
sensitivity, due to subsequent activation of Ca 2+ channels by 
nAChR-mediated depolarisation. The L~lc-b Ca 2+ channel 
facilitates Ca 2+ currents after repeated epolarisation [24]. 
The assay permits sensitive detection of nAChR-expressing 
cell clones and quantitative assessment of the stability with 
time of culture of these clones. The results of functional stud- 
ies obtained with HEK-293/cO cells stably expressing the c~3/ 
134 subtype of nAChR are similar to those of Wong et al. [21] 
obtained with HEK-293 cells transiently expressing the same 
nAChR subtype. 
2. Materials and methods 
2.1. Materials 
The cDNA clones for the rat a3 [25] and [34 [26] nAChR subunits 
were kindly provided by Drs. Steve Heinemann and Jim Boulter of 
the Salk Institute, San Diego. HEK-293 cells stably expressing the 
L0tlC_b Ca 2+ channel (HEK-293/otl [23]) were a generous gift from 
Dr. Franz Hofmann (Institute of Pharmacology and Toxicology, 
Technical University Munich). 
2.2. Eukaryotic expression vectors 
The rat a3 (PCA48E) nicotinic acetylcholine r ceptor subunit cod- 
ing sequence and the rat ~4 (ZPC13) coding sequence were subcloned 
into the expression vector pcDNA 3 (Invitrogen, San Diego, CA), and 
the constructs were introduced into E. coli strain C600 [27,28]. Plas- 
mid DNA was purified using a column based method (Qiagen) and 
stored in TE buffer (20 mM Tris; 1 mM EDTA, pH 8.0) at -20°C 
until transfection. 
2.3. Cell culture 
Human embryonic kidney cells (HEK-293) cells were obtained from 
the American Tissue Type Culture Collection (ATCC CRL 1573; 
Rockville, MD). Cells were grown in Dulbecco's modified Eagle's 
medium (DMEM) containing 15% foetal calf serum (FCS) and main- 
tained in a water-jacketed incubator at 37°C, 10% COe. To keep the 
cells in the exponential phase of growth, they were harvested every 
3 days and plated at a density of 1.5 × 104 cells/cm 2. HEK-293 cells 
stably transfected with the LOtlC-b Ca 2+ channel (HEK-293/al [23]) 
were cultured under the same conditions as HEK-293 cells, except 
All rights reserved. 
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Fig. 1. Expression of rat ct3/[34 nAChR in HEK-293/ctl cells, as monitored by Ca 2+ imaging. The relative intracellular Ca 2+ concentration 
[Ca2+]~ was determined by fura-2 fluorescence emission at 510 nm, at the two excitation wavelengths 340 and 380 nm, and intensity ratios were 
calculated, as described in Section 2. The left micrographs (A,C) show the transfected cells (24 h after initiation of transfection) prior to the ap- 
plication of nicotine. In (A) HEK-293/0d cells transiently transfected with ~3/~4 nAChR plasmids are shown. They display only background 
levels of fura-2 fluorescence. In the experiment shown, the density of cells was kept low in order to permit single-cell resolution of the fluores- 
cence measurements. Following stimulation with nicotine (100 ~tM), a portion of the cells responded with a strong increase in [Ca2+]i (B). In 
(C,D) HEK-293/otl cells stably transfected with 0t3/1~4 nAChR plasmids are shown. [Ca2+]i before (C) and after (D) stimulation with nicotine 
(100/aM). In the experiment shown, the density of cells was kept relatively high (approx. 150 cells in the section shown) in order to permit esti- 
mation of the high efficiency of transfection (close to 100%). (Bottom) The ratio of HEK-293/ctl cells showing robust Ca 2+ influx (ratio value 
above 1.5) upon stimulation by nicotine, and the total number of cells is displayed for four experiments each of transient and stable transfec- 
tion. In these experiments, the transfection efficiencies were 54 and 96%, respectively. 
that the medium was supplemented with 0.75 iag/ml G418 (Gibco/ 
BRL). 
2.4. Transient ransfection of HEK-293 and HEK-293/o:l cells 
Cells of passages 4-15 were used for transfection experiments. 24 h 
prior to transfection, cells were plated on fibronectin-coated cover- 
slips in 24-well culture dishes. Transfection was achieved by calcium 
phosphate-DNA precipitation [29], using 1 /.tg DNA/cover-slip, i.e. 0.5 
~tg DNA of each subunit. The DNA was dissolved in 90 ~tl sterile H20 
and 100 lal 2 × BBS (50 mM BES (N,N-bis[2-hydroxyethyl]-2-ethane- 
sulfonic acid, Sigma); 1.5 mM Na2HPO4; 280 mM NaCI, adjusted to 
pH 6.95; 22°C). After drop-wise addition of 10 ~1 2.5 mM CaC12, the 
solution was gently mixed and incubated for 15 min at room tem- 
perature. The solution was then added drop-wise to the medium (1 
ml) covering the cells, and the mixture was incubated for 24 h at 37°C, 
10% CO2. After replacing the medium, cells were cultured for another 
18-24 h and were then subjected to the screening procedures described 
below. 
2.5. Stable transfection of HEK-293/ot1 cells 
HEK-293/al cells were plated on 35 mm 2 cell culture dishes 24 h 
prior to transfection. A mixture of 1 ~tg each of the expression vectors 
for the nAChR subunits and puromycin (Gibco/BRL), in 600 ~tl trans- 
fection solution, and 2.4 ml medium were used to transfect the cells by 
means of calcium-DNA precipitation. The cells co-transfected with 
the three expression vectors were selected on the basis of puromy- 
cin/geniticin resistance. 
Cells were maintained for 2 weeks in DMEM containing 15% FCS, 
0.75 ~tg/ml G418 and 0.5 Ixg/ml puromycin. After massive cell death 
had occurred, a few double-resistant clones could be isolated by the 
use of cloning rings. Isolated clones were cultivated in selection med- 
ium for another 6 weeks. They were then screened by Ca 2+ imaging 
for functional expression of nicotinic receptors. Positive clones were 
submitted to electrophysiological studies. 
2.6. Fura-2 measurements 
Ca 2+ influx induced by stimulation with nicotine was measured 
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with single-cell resolution using the Hamamatsu Argus 50/CA imaging 
system [30]. Cells transfected with a3/134 nAChR DNA were plated on 
fibronectin-coated cover-slips for 72 h, followed by incubation (for 1 h 
at 37°C) with a solution (2 ~tM) of membrane-permeable fura-2-acet- 
oxy methyl ester (fura-2-AM, Molecular Probes), washing and incu- 
bation for 1 h at room temperature in Ringer's solution (130 mM 
NaCI; 5 mM KC1; 1 mM CaC12; 1 mM MgCI2; 2 mM KH2PO4; 
5 mM glucose; 20 mM HEPES; pH 7.4). The latter incubation results 
in the conversion by cytoplasmic esterases of fura-2-AM to water- 
soluble, membrane-impermeable Ca2+-chelating fura-2. Cover-slips 
were then placed into the recording chamber (1 ml volume) mounted 
on the stage of an Axiovert 135TV inverted microscope (Zeiss), and 
the fluorescence intensities at 510 nm were measured every 20 s at two 
excitation wavelengths, 340 and 380 nm, respectively. Fluorescence 
ratio data analysis [30] was performed with the software provided 
by Hamamatsu and yielded relative values of intracellular calcium 
ion concentration, [Ca2+]i. 
Usually 30 fluorescence measurements were taken at intervals of 20 
s. During measurements 2 6 and 17-21 the medium (Ringer, contain- 
ing 2.5 mM CaCI2) was exchanged for one containing nicotine (100 
I.tM). In between and thereafter the cells were kept in medium without 
nicotine. Blocking experiments (with hexamethonium (100 laM, Fluka) 
and nitrendipine (1 ~tM, Research Biochemicals Int.), respectively) 
were performed by supplementing the medium of fluorescence mea- 
surements 7 21 with the blocking agent. All medium changes were 
performed manually using 5 ml of solution in a Gilson pipette, which 
sufficed to wash out and replace the previous solution in the 1 ml 
recording chamber. 
2. 7. Electrophysiological measurements 
Whole-cell current recordings from transiently transfected cells were 
performed 12 24 h after transfection, those with stably transfected 
cells 1248 h after plating, according to standard patch-clamp techni- 
ques [31] using an EPC-7 patch-clamp system (List Electronics, Darm- 
stadt). The bathing solution was composed of (mM) NaCI 124; KC1 
3.25; MgC12 2; CaC12 2; D-glucose 11; HEPES 10 (pH 7.4; 275 
mOsm), and the internal pipette solution contained (mM) CsF 120; 
CsCI 10; Cs-EGTA 10; HEPES 10 (pH 7.3; 280 mOsm). The micro- 
electrodes were pulled from borosilicate glass (external diameter 1.6 
mm), and the resistance of the fire-polished pipettes was 5-7 M~ 
using the external and internal solutions described above. After for- 
mation of a high-resistance s al with the cell under investigation, 
capacitance transients were minimised using the C-Fast facility of 
the system. No compensation was made for series resistance. 
Single-channel recordings were made on outside-out patches using a 
double-barrelled glass theta tube for fast drug application, as de- 
scribed previously [10]. Whole-cell currents were induced by fast ap- 
plication of the test substances by means of a U-tube reversed-flow 
device [32], positioned near the cell. The cells were superfused with the 
bathing solution at a rate of 1.5-3.0 ml/min. In most whole-cell ex- 
periments, atropine (1 txM) was included in the bathing solutions in 
order to inhibit intrinsic muscarinic response. For voltage-jump ex- 
periments, the command potentials were applied and computer-con- 
trolled using the CLAMPEX application of pClamp. The cell mem- 
brane was held at -70 mV and pulsed to the test potentials ( -30 to 
+10 mV) for 50 ms by a 1 s interpulse interval at the holding potential 
before application of the next pulse. 
Signals were low-pass (Bessel) filtered at 3.15 kHz (whole-cell meas- 
urements) or 1 kHz (single-channel recordings), digitised at 1 kHz 
(whole-cell) or 10 kHz (single-channel), and analysed on a PC using 
the pClamp software package version 6.03 (Axon Instruments). The 
whole-cell responses were normalised to the response induced by the 
maximal agonist concentration used. Dose-response curves represent 
fits of the data to the Hill equation. All data are presented as mean + 
standard error. 
3. Results 
3. l. Ca r+ imaging as a detection method for nA ChR-expressing 
cells 
Transient expression of the rat t~3/134 subtype of neuronal  
nAChR was initially achieved in normal  HEK-293 cells, with 
the expression level of functional nAChR tested by whole-cell 
patch-clamp recordings in the presence and absence of nico- 
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Fig. 2. Pharmacological specificity of Ca 2+ influx into rat c¢3/134 
nAChR-expressing HEK-293/ctl cells. The relative intracellular Ca 2+ 
concentration [Ca2+]i was determined at intervals of 20 s in the 
course of experiments in which nicotine (100 I, tM) was applied twice 
(for 100 s each), as indicated by the bars. In the control experiment 
((>), normal medium was given before, in between and after the ap- 
plication of nicotine. In the other two experiments, hexamethonium 
(100 ~tM; []) and nitrendipine (1 [aM; A), respectively, were given 
after the first application of nicotine. The nicotinic antagonist and 
the Ca2+-channel b ocker reduced the second nicotine-induced re- 
sponse to 8.8 and 19.1%, respectively, of the previous value. 
tinic agonist. Transfection efficiencies of 40 60% were rou- 
tinely achieved, with robust nicotinic responses detected be- 
tween 12 and 48 h after initiating transfection. Transfection 
with the DNA of only one subunit did not render the cells 
responsive to nicotinic agonist, as has been observed pre- 
viously by others for the expression in Xenopus oocytes and 
HEK-293 cells [21,25,26]. This finding also excludes the pres- 
ence of endogenous nAChR subunits in HEK cells that couple 
to the introduced exogenous ubunit. 
Because whole-cell electrophysiological recordings are 
rather t ime-consuming and hence do not lend themselves to 
the assessment of nAChR expression levels of large numbers 
of cells, we used a screening assay that takes advantage of the 
functional coupling of ectopically expressed nicotinic recep- 
tors to voltage-gated Ca 2+ channels and monitors agonist-in- 
duced Ca 2+ influx into transfected cells. For this purpose, we 
employed as ectopic expression system HEK-293/ctl cells, 
which stably express a voltage-gated Ca 2+ channel [23]. The 
presence of functional nAChR channels can then be moni- 
tored by the activity of Ca 2+ channels, provided that sufficient 
local depolarisation is produced when the cells are exposed to 
nicotinic agonist. The functional coupling of nicotinic recep- 
tors with voltage-gated Ca 2+ channels results in an amplifica- 
tion and an elongation in time of the agonist-induced ion 
influx into the cell. As shown in Fig. 1A,B, intracellular cal- 
cium ion levels [Car+]i well above background (minimal ratio 
value 1.5) were observed in more than 50% of HEK-293/cd 
cells co-transfected with rat nAChR c¢3 and [34 plasmids. The 
nicotine-induced stimulation of Ga r+ influx into cells transi- 
ently transfected with nAChR could be blocked by saturating 
concentrations of the nicotinic antagonist hexamethonium 
(100 ~tM) and (to a lesser extent) by nitrendipine (1 taM), a 
blocking agent of voltage-gated Ca z+ channels (not shown). 
These findings suggest hat agonist-induced activation of ni- 
cotinic receptors results in Ca r+ influx through voltage-gated 
Ca 2+ channels (which are activated by nAChR-mediated local 
depolarisation). In addition, some Ca r+ influx may occur 
through the nAChR channel itself. These results show that 
Ca 2+ imaging is a suitable method for the identification of 
HEK-293/~I cells transfected with e¢3/~4 nAChR.  
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Fig. 3. Samples of recordings and current-voltage relationship of single-channel currents activated by acetylcholine (100 laM) in an outside-out 
patch excised from a HEK-293/al cells stably expressing the rat a3/134 nAChR. Data shown were filtered at 1.0 kHz. Within the linear range 
of the I- V plot, the channel conductance was determined to29 + 1 pS (n = 3). 
3.2. Stable expression of a3/~4 nAChR in HEK-293/al cells 
In order to obtain stable clones of c¢3/134 nAChR-expressing 
HEK-2931c¢l cells, the transfected cells were cultured for 2 
weeks in the presence of geneticin (0.75 ~tg/ml) and puromycin 
(0.5 ~g/ml), as described in Section 2. 12 double-resistant 
clones were obtained, separated, and were grown for another 
6 weeks under selection conditions. Using Ca z+ imaging as 
functional assay, three of the clones responded to the applica- 
tion of nicotine (100 ~tM) with a Ca 2+ influx (150 cells per 
dish and 3 dishes per clone were tested). Approx. 96% of the 
cells of each dish/clone responded to nicotine with a strong 
Ca z+ influx (Fig. 1C,D). This value compares well with elec- 
trophysiological tests of 100 cells (see below), of which 98 cells 
produced sizeable whole-cell currents when exposed to nico- 
tine. Agonist-induced Ca 2+ influx was reversible upon wash- 
ing with agonist-free solution, reproducible when agonist was 
applied again, and could be blocked with pharmacological 
specificity (Fig. 2). Meanwhile, the stable a3/[34 nAChR-ex- 
pressing HEK-293/al cells have been kept in culture for sev- 
eral months, without significant loss of their nAChR activity. 
3.3. Preliminary electrophysiological eharacterisation of ~31~4 
nAChR-expressing HEK-2931o~l cells 
In outside-out patches excised from HEK-293 cells stably 
expressing the c¢3/IM nAChR, in addition to the L{21c b Ca 2+ 
channel, ACh (100 ~tM) activated single-channel currents (Fig. 
3). Only one channel conductance was observed, which from 
the linear range of the /-V plot, in four independent sets of 
experiments, was 29.4 + 1.0 pS. This is in close agreement with 
the major conductance we observed previously in PC12 cells 
[10]. 
In whole-cell recordings the following were present: (i) an 
L-type Ca 2+ current, which could be blocked by the dihydro- 
pyridine derivative nimodipine (Fig. 4); and (ii) an ACh-acti- 
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Fig. 4. Whole-cell responses of HEK-293/ctl cells stably expressing the rat ct3/134 nAChR and an L-type Ca 2+ channel. (a) Activation by depol- 
arisation of an L-type Ca 2+ channel that is inhibited by preincubation (1 min) with nimodipine (1 p-M). After wash-out for 3 min, the block 
by nimodipine was removed. (b) Sample recordings (representative of four series of experiments) of whole-cell currents activated by 2-s pulses 
of ACh (200 gM) in the absence (left) and presence (middle) of d-tubocurarine (100 gM), and after wash-out for 10 min (right). (c) Dose-re- 
sponse curve for acetylcholine. Each open circle denotes the mean response value obtained from three ceils. The solid line represents he Hill 
equation fit which yielded an EC~0 of 147+4 mM and a Hill coefficient of 1.98. 
vatable current, which could be blocked by (in the following 
order) mecamylamine, hexamethonium, decamethonium, di-
hydro-13-erythroidine (all not shown) and d-tubocurarine 
(Fig. 4). At more positive membrane potentials, inward recti- 
fication was observed. Interestingly, the ACh-induced currents 
recorded from different cells showed considerable variation in 
the rate and level of desensitisation. From dose-response 
curves for ACh, EC50 values of 145 + 12 gM, and Hill coeffi- 
cients between 1.6 and 1.98 were obtained (3 experiments, Fig. 
4). Together with dose-response curves for the agonists cyti- 
sine and nicotine (not shown), an order of potency of cytisine 
- nicotine > acetylcholine was deduced. The Hill coefficients 
for all agonists tested were significantly higher than unity, 
suggesting that two (or more) molecules of agonist are re- 
quired to activate this nAChR subtype. The distribution of 
response amplitudes to 100 ktM ACh of HEK-293 cells stably 
expressing the ct3/134 nAChR cultured for (~8 weeks was quite 
broad, varying between 10 and 2000 pA, with an average 
value of 360 pA. It is unlikely that this was due to the pres- 
ence of varying amounts of homopentameric and heteropen- 
tameric nAChRs because (i) tx3 subunits apparently do not 
form functional homopentamers [21,25], and (ii) the Hill coef- 
ficients obtained with low responding cells were not signifi- 
cantly smaller than those obtained with high responding cells. 
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4. Discussion 
Human embryonic kidney (HEK) cell lines are well estab- 
lished ectopic expression systems [1(~18,21,33,34]. Although 
relatively high levels of transient expression of ct3/]34 nicotinic 
receptors have been achieved in these cells ([21] and this pa- 
per), stable expression should provide several advantages, in- 
cluding more reproducible and longer lasting levels of nAChR 
expression, which are prerequisites for detailed single-channel 
studies and the practical application of these cells for drug 
screening. At present, we have achieved in HEK cells the 
expression of t~3/~4 nAChR that persists for several months, 
but the level of receptor expression is still quite variable be- 
tween different transfected cells. The functional assay em- 
ployed in the selection of nAChR-expressing cells, however, 
may also be suitable for the selection of high responders from 
among transfected cells. 
The functional assay employed takes advantage of the fact 
that activation by agonist of nicotinic receptors produces a 
local depolarisation that, if large enough, could trigger the 
activation of voltage-gated Ca 2+ channels. By employing a 
HEK cell line that stably expresses an L-type Ca 2+ channel, 
the desired functional coupling of the two types of ion chan- 
nels was indeed achieved (Figs. 1 and 2). The assay can detect 
HEK-293/cd cells that have a sufficiently high level of nAChR 
expression in order to produce, in the presence of agonist, 
membrane depolarisation that is above the threshold of 
Ca2+-channel activation. Only properly assembled and func- 
tional nAChR are detected, which is an important advantage 
in comparison to binding assays. Binding assays are also more 
time-consuming, more prone to experimental rtefacts, and 
less sensitive. 
The electrophysiological data obtained so far are only pre- 
liminary, yet it appears that the et3/[M subtype of nAChR, 
when stably expressed in HEK-293 cells, closely resembles 
the major nAChR of PC12 cells [10], and also type III re- 
sponses recorded from cultured embryonic hippocampal neu- 
rons [11,12]. Based on patch-clamp studies with Xenopus oo- 
cytes ectopically expressing various combinations of nAChR 
subunits, it has been proposed that type III responses are 
subserved by a combination of ct3 and [34 subunits [11]. 
Therefore, our results suggest hat this subtype may indeed 
represent he major ganglionic nAChR. The HEK cell line 
stably expressing this receptor may help to characterise 
further its pharmacology and functional properties. 
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